MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3904/kjim.2019.376

Медицинская библиотека · The Korean journal of internal medicine · 2020

Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma.

Kim Yu Ri, Kim Soo-Jeong, Cheong June-Won, Kim Yundeok, Jang Ji Eun, Cho Hyunsoo, Chung Haerim, Min Yoo Hong, Yang Woo Ick, Cho Arthur, Kim Jin Seok

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND/AIMS: Although the use of surveillance 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is discouraged in patients with diffuse large B-cell lymphoma, its usefulness in different subtypes has not been thoroughly investigated.

METHODS

We retrospectively evaluated 157 patients who showed positive results on surveillance FDG-PET/CT every 6 months following complete response for up to 5 years. All of the patients also underwent biopsies.

RESULTS

Seventy-eight (49.6%) of 157 patients had true positive results; the remaining 79 (50.3%), including eight (5.1%) with secondary malignancies, were confirmed to yield false positive results. Among the 78 patients with true positive results, the disease in seven (8.9%) had transformed to a different subtype. The positive predictive value (PPV) of FDG-PET/CT for aggressive B-cell non-Hodgkin's lymphoma (NHL) was lower than that for indolent B-cell or aggressive T-cell NHL (p = 0.003 and p = 0.018, respectively), especially in patients with a low/low-intermediate international prognostic index (IPI) upon a positive PET/CT finding. On the other hand, indolent B-cell and aggressive T-cell NHL patients showed PPVs of > 60%, including those with low/low-intermediate secondary IPIs.

CONCLUSION

The role of FDG-PET/CT surveillance is limited, and differs according to the lymphoma subtype. FDG-PET/CT may be useful in detecting early relapse in patients with aggressive T-cell NHL, including those with low/low-intermediate risk secondary IPI; as already known, FDG-PET/CT has no role in aggressive B-cell NHL. Repeat biopsy should be performed to discriminate relapse or transformation from false positive findings in patients with positive surveillance FDG-PET/CT results.

Для цитирования: Kim Yu Ri, Kim Soo-Jeong, Cheong June-Won, Kim Yundeok, Jang Ji Eun, Cho Hyunsoo, Chung Haerim, Min Yoo Hong, Yang Woo Ick, Cho Arthur, Kim Jin Seok. Different roles of surveillance positron emission tomography according to the histologic subtype of non-Hodgkin's lymphoma.. The Korean journal of internal medicine. 2020. DOI: 10.3904/kjim.2019.376.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.